Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
US10047151B2 · kind B2 · utility
16Cited by
57References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2016 |
| Grant date | Aug 14, 2018 |
| Priority date | — |
| Expiry date | May 23, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/60
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Uses of the protein cereblon as a predictor of clinical sensitivity to cancer, inflammatory diseases, and patient response to drug treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.